Angiotensin II-mediated development of vascular diseases.
about
Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor5-Lipoxygenase pathway in experimental abdominal aortic aneurysmsANG II stimulates phospholipase D through PKCzeta activation in VSMC: implications in adhesion, spreading, and hypertrophyEssential role of PKC-zeta in normal and angiotensin II-accelerated neointimal growth after vascular injuryHigh-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytesDecreased blood pressure in NOX1-deficient miceVascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.Cognitive performance in hypotensive persons with spinal cord injuryAngiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin IIGenomic analysis of circulating cells: a window into atherosclerosisEstablishment of a new murine elastase-induced aneurysm model combined with transplantationAngiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways.Impaired glutathione redox system paradoxically suppresses angiotensin II-induced vascular remodeling.Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient miceSmall RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cellsVitamin D receptor signaling inhibits atherosclerosis in miceThe Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathwayAngiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient miceHypertension, kidney, and transgenics: a fresh perspective.Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation2-Photon Characterization of Optical Proteolytic Beacons for Imaging Changes in Matrix-Metalloprotease Activity in a Mouse Model of AneurysmNovel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cellsANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.Molecular mechanisms of thoracic aortic dissection.Vitamin D receptor signaling in renal and cardiovascular protection.Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.Role of renin-angiotensin system in adipose tissue dysfunction.Cyclophilin A: promising new target in cardiovascular therapy.Rho-kinase: important new therapeutic target in cardiovascular diseases.Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis.Apolipoprotein-J prevents angiotensin II-induced apoptosis in neonatal rat ventricular cells.The salted artery and angiotensin II signaling: a deadly duo in arterial diseaseRegulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.Angiotensin II Infusion Does Not Cause Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Rats.Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
P2860
Q24815241-88AB4707-B51A-4610-BAC1-CFDD76D7F261Q27342659-B3C2E3C5-4CB4-4E19-B442-6C139FA78049Q28571340-1EA286CF-6D96-4AF8-8D73-CF6C2506E04EQ28579623-5D360C7B-5E20-46D4-A4F9-F8DDD8831714Q28582700-55A2BEF1-FD7F-4724-AEDF-1EB5453504C8Q28588922-14EFD1E5-F8C9-42A1-A2F3-399206B1973DQ33755987-A1291EB7-23AD-4C51-9E47-C3983BB02630Q33972516-184F5707-C02A-4AE4-9A7A-4F54CC5187EDQ34150434-57C49691-427B-479E-B548-D15F5F7CBE10Q34561198-72E32543-8F2B-4A6F-81B0-F92C06112654Q35005805-AC66F87E-EEA7-4994-B350-3782F59FCE22Q35214234-E14DD49F-5D05-45E5-962D-AF750E70A559Q35273462-F60C9871-7A54-4303-B662-3B236DE827B7Q35364697-D24D5091-1D0A-4C9F-82FC-80A9E8A16689Q35839118-F38822F0-F003-47C1-80B5-04E16BFDA79FQ35870375-8E83B466-DC55-40D2-9273-A92B96E7210EQ35939806-D9F925A2-BD45-4783-9A28-1049D56E6606Q36065512-9C8CFC31-C71F-43BF-9B44-3F75752CC911Q36182961-F584621A-AF67-46D6-9914-266D7FBCB8EFQ36198189-BC04CD82-2AB0-4C4B-91FC-D41723673824Q36377589-5823A0C9-89B3-49AC-A1F3-ED18469EDDB8Q36443015-2D909227-95C6-44FC-9D4B-DDCB696BCD99Q36771716-C9F5B3F9-3B78-4356-846F-13125623ABEDQ36772351-52C84EE9-6F70-4F0E-A111-6176530EF74EQ37149254-E086C42A-FD26-4771-8B11-28787B64AEBFQ37200287-173C5D5C-07BF-4222-8FDC-8B9A26F1A1D8Q37210834-F6EAABCF-74BA-428F-AC61-560C2645D3E1Q37230136-A02C7699-082D-4BF0-B169-FF09FBC332AAQ37366356-20A8B1A7-3FB9-45E7-BD7C-5CECCF605CE4Q37452257-EE11A317-837A-4BB1-970D-C21C3795C5AEQ37466234-0B375A0F-7A44-40BF-A528-0662975C4319Q37801787-EE9D4674-C544-401F-8B39-ECF30B9745E0Q37881804-868A0723-EF57-4133-9ECE-478A53750BA9Q41867537-36D8189A-0D34-4473-9DA0-A860393B0B99Q42230369-FE314199-EC36-4CF9-821E-EFB261E7EDDCQ42730474-B3C9FB85-075D-493F-8FE5-EE1DE6B44674Q44011765-69B85052-41E7-4AE9-A5B8-AE57B564225FQ46255934-4415241D-0639-42E6-AF36-20061C2043D6Q46813413-394660E9-AFCA-40DC-89D6-37AED18DE107Q50879167-96ACEA5E-13F8-4C36-ACC2-EF3FE7E73B31
P2860
Angiotensin II-mediated development of vascular diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiotensin II-mediated development of vascular diseases.
@ast
Angiotensin II-mediated development of vascular diseases.
@en
type
label
Angiotensin II-mediated development of vascular diseases.
@ast
Angiotensin II-mediated development of vascular diseases.
@en
prefLabel
Angiotensin II-mediated development of vascular diseases.
@ast
Angiotensin II-mediated development of vascular diseases.
@en
P1476
Angiotensin II-mediated development of vascular diseases.
@en
P2093
Alan Daugherty
Lisa Cassis
P304
P356
10.1016/J.TCM.2004.01.002
P577
2004-04-01T00:00:00Z